IHH Healthcare (5225) Fundamentals 2026 — P/E 34.8x, Revenue Analysis | SniperIQ
IHH Healthcare (5225) is a MY-listed Healthcare company in Medical - Care Facilities with a market capitalization of RM73.6B, trading at RM8.33 on the KLS. This SniperIQ fundamentals page covers IHH Healthcare's valuation (P/E 34.8x, P/B 2.5x), profitability (net margin 8.1%), revenue (RM25.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is IHH Healthcare's market cap?
IHH Healthcare (5225) has a market capitalization of approximately RM73.6B, trading at RM8.33 on the KLS. Market cap moves with the live share price.
What is IHH Healthcare's P/E ratio?
IHH Healthcare's trailing twelve-month P/E ratio is 34.8x, with a price-to-book (P/B) of 2.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is IHH Healthcare?
IHH Healthcare runs a net profit margin of 8.1%, a gross margin of 49.1%, and an operating margin of 13.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does IHH Healthcare generate?
IHH Healthcare reported revenue of RM25.7B for fiscal year 2025, with net income of RM2.1B and earnings per share (EPS) of 0.24. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does IHH Healthcare pay a dividend?
IHH Healthcare offers a trailing dividend yield of about 1.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is IHH Healthcare financially healthy?
IHH Healthcare carries a debt-to-equity ratio of 0.51x and a current ratio of 0.59x, with a market beta of 0.14. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is IHH Healthcare a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For IHH Healthcare (5225) the key facts are: market cap RM73.6B, P/E 34.8x, revenue RM25.7B, 52-week range 6.57-10.48. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track IHH Healthcare's full fundamentals live
Get IHH Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.